{"id":"W3124845551","doi":"10.1016/s2213-2600(20)30517-8","title":"Long-term safety and efficacy of lumacaftor–ivacaftor therapy in children aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study","year":2021,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children; British Columbia Children's Hospital","funders":"Cystic Fibrosis Trust; AbbVie; National Institute for Health and Care Research; Gilead Sciences","keywords":"Ivacaftor; Tolerability; Cystic fibrosis; Medicine; Placebo; Internal medicine; Cystic fibrosis transmembrane conductance regulator; Clinical endpoint; Adverse effect; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001566287,0.001063866,0.002231901,0.000314399,0.0004739185,0.001124914,0.0006206648,0.001834923,0.001978186],"category_scores_gemma":[0.002027876,0.0004767728,0.002450756,0.0003493194,0.001154289,0.001160906,0.0003388381,0.003358078,0.000504962],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009133931,"about_ca_system_score_gemma":0.001235862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001724568,"about_ca_topic_score_gemma":0.002749671,"domain_scores_codex":[0.9990184,0.0003776661,0.00005481806,0.000174254,0.0001285902,0.0002461782],"domain_scores_gemma":[0.9983978,0.0004032281,0.0004304549,0.0001178895,0.0001260207,0.0005246117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8648868,0.0266331,0.02414316,0.0007316195,0.002394775,0.0003774815,0.0003596133,0.0007285615,0.01211318,0.0001270146,0.001642506,0.06586217],"study_design_scores_gemma":[0.4161436,0.4618215,0.1137642,0.0001714016,0.002073586,0.0004413997,0.0002283079,0.0005874391,0.002284305,0.0001356952,0.00227316,0.00007535308],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961428,0.002486661,0.0001041727,0.0001500227,0.00006653762,0.000185435,0.0004333988,0.00001625977,0.0004147514],"genre_scores_gemma":[0.9959041,0.001420462,0.0003104233,0.0003761722,0.0001369952,0.0003699791,0.0008629173,0.00000887543,0.00061013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002231901,"threshold_uncertainty_score":0.008283436,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06946883311109206,"score_gpt":0.3966840902077589,"score_spread":0.3272152570966668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}